Skip to content

Penumbra PEN Total Liabilities

Total Liabilities at other companies

Johnson & Johnson logo
Johnson & JohnsonJNJ
$119.71B+3.6%
Stryker logo
StrykerSYK
$23.31B-7.0%
Medtronic logo
MedtronicMDT
$42.96B-1.1%
Boston Scientific logo
Boston ScientificBSX

Other financials

Income statement

See full
Revenue$374.8M+15.6%
Gross profit$253.4M+17.4%
Operating income$38.2M-5.2%
Net income$32.6M-16.9%
EPS (diluted)$0.82-18.0%

Balance sheet

See full
Cash & equivalents$241.3M-35.8%
Total debt$216.2M-2.0%
Total equity$1.5B+21.5%
Total assets$1.9B+19.2%

Cash flow

See full
Operating cash flow$87.0M+77.6%
CapEx$13.7M+1.5%
Free cash flow$73.3M+106%

Valuation

See full
Market cap$12.48B+25.1%
Enterprise value$12.45B+26.8%
P/E72.9×-163×
P/S8.6×+0.5×

Profitability

See full
Gross margin67.4%+3.7pp
Operating margin12.9%+9.8pp
Net margin11.8%+8.4pp
FCF margin14.6%+2.5pp

Returns & leverage

See full
Return on equity12.7%+9.2pp
Debt / equity0.1×0.0×
Current ratio-0.3×

Where this comes from

Reported directly by Penumbra in its filing.

Tagged under the XBRL concept us-gaap:Liabilities.

The official record: Penumbra’s 10-Q, filed May 6, 2026, on SEC EDGAR. View the filing →

Ask your AI about Penumbra's total liabilities.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Penumbra's total liabilities?
Penumbra (PEN) reported total liabilities of $424.63M in Q1 2026.
How has Penumbra's total liabilities changed year-over-year?
Penumbra's total liabilities increased by 11.6% year-over-year, from $380.43M to $424.63M.
What is the long-term trend for Penumbra's total liabilities?
Over 5 years (2020 to 2025), Penumbra's total liabilities has grown at a 16.6% compound annual growth rate (CAGR), from $185.2M to $398.92M.
What does total liabilities mean?
The total amount of debt and financial obligations the company owes to creditors and other parties.
How do you interpret total liabilities?
Rising total liabilities relative to assets may indicate increased financial leverage and potential solvency risk.
How does total liabilities compare across companies?
Medical device companies generally maintain moderate leverage; high total liabilities relative to peers may signal aggressive debt-funded growth.